Myco Biotech shares will result in the BS Myco Biotech being a subsidiary of the Company. Shareholder name Before Acquisition After Acquisition 1. Bangjak Green Energy Company Limited 399,990 shares

Million. o Dividend payment of 2018 (April – December) to shareholders whose names appear in the shareholder register as of March 13, 2019 for 280 Million shares at 0.10 Baht per share. Totaling of Baht

Receipt) for the purchase of fuel in H1. Non-current liabilities have decreased as the Saraburi Acquisition loan and the Hua-Pha-Way Kiln 7 loan continue to be repaid. Shareholder equity reduced with the

shareholder at Annual General Meeting resolved to approve the cash dividend payment from the operating results of 2H 2017 at THB 0.018 per share (a total of THB 62mn). The total dividend payment from 2017

in long-term liabilities due to the 330mTHB term loan used to acquire Saraburi Quicklime impacted total liabilities. Shareholder equity increased in-line with the additional net result. Balance Sheet

related to the Company since its authorized directors and major shareholders are Kewkacha family who is also the major shareholder and director of the Company as detail below; Related Person Relationship

LIABILITIES 677.43 28.68% 655.42 28.85% SHAREHOLDERS’ EQUITY Shareholder equity 383.00 383.00 Registered capital Issued and Paid up capital 383.00 16.22% 383.00 16.86% Premium on stock 519.67 22.00% 519.67

Company Limited (“VGI”), a major shareholder of the Company (as detailed in the Information Memorandum on Connected Transaction and Asset Acquisition of Master Ad Public Company Limited (Enclosure 3)) (the

1.78 times in 2017 due to the reduction of the account payables which was lower than the reduction of the shareholder equity to be mentioned in the next item. Shareholders’ Equity As ended June 30, 2018

-current liabilities 37.56 1.49% 36.51 1.55% TOTAL LIABILITIES 810.54 32.09% 677.43 28.68% SHAREHOLDERS’ EQUITY Shareholder equity 383.00 383.00 Registered capital Issued and Paid up capital 383.00 15.16